​

Insight Molecular Diagnostics (IMDX) Revenue & Revenue Breakdown

OverviewForecastFinancialsChartTranscripts

Insight Molecular Diagnostics Revenue Highlights

Latest Revenue (Y)

$1.88M

Latest Revenue (Q)

$518.00K

Main Segment (Y)

Pharma Services

Main Geography (Y)

UNITED STATES

Insight Molecular Diagnostics Revenue by Period

Insight Molecular Diagnostics Revenue by Year

DateRevenueChange
2024-12-31$1.88M25.15%
2023-12-31$1.50M56.89%
2022-12-31$958.00K-87.60%
2021-12-31$7.73M535.44%
2020-12-31$1.22M100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--

Insight Molecular Diagnostics generated $1.88M in revenue during NA 2024, up 25.15% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Insight Molecular Diagnostics Revenue by Quarter

DateRevenueChange
2025-06-30$518.00K-75.77%
2025-03-31$2.14M43.88%
2024-12-31$1.49M1192.17%
2024-09-30$115.00K10.58%
2024-06-30$104.00K-40.91%
2024-03-31$176.00K-43.95%
2023-12-31$314.00K-26.81%
2023-09-30$429.00K-7.34%
2023-06-30$463.00K55.89%
2023-03-31$297.00K-108.37%
2022-12-31$-3.55M-449.07%
2022-09-30$1.02M-50.80%
2022-06-30$2.07M45.15%
2022-03-31$1.42M-60.32%
2021-12-31$3.59M264.74%
2021-09-30$984.00K-51.53%
2021-06-30$2.03M80.60%
2021-03-31$1.12M123.46%
2020-12-31$503.00K-9.37%
2020-09-30$555.00K288.11%
2020-06-30$143.00K793.75%
2020-03-31$16.00K100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31--

Insight Molecular Diagnostics generated $518.00K in revenue during Q2 2025, up -75.77% compared to the previous quarter, and up 294.32% compared to the same period a year ago.

Insight Molecular Diagnostics Revenue Breakdown

Insight Molecular Diagnostics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Pharma Services$1.86M

Insight Molecular Diagnostics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Pharma Services (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25
Laboratory Services$494.00K-
Pharma Services-$2.14M

Insight Molecular Diagnostics's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Laboratory Services (100.00%).

Insight Molecular Diagnostics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24
Asia Pacific$145.00K
GERMANY$18.00K
UNITED STATES$1.67M

Insight Molecular Diagnostics's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (91.12%), Asia Pacific (7.90%), and GERMANY (0.98%).

Quarterly Revenue by Country

CountryJun 25Mar 25
Europe$24.00K-
UNITED STATES$494.00K$2.14M

Insight Molecular Diagnostics's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (95.37%), and Europe (4.63%).

Insight Molecular Diagnostics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CDXSCodexis$59.34M$7.54M
SGMOSangamo Therapeutics$57.80M$6.44M
OABIOmniAb$26.39M$2.24M
IVVDInvivyd$25.38M$11.30M
CCCCC4 Therapeutics$20.76M-
IMDXInsight Molecular Diagnostics$1.88M$518.00K
PRLDPrelude Therapeutics-$4.00M
PEPGPepGen--
MISTMilestone Pharmaceuticals--

IMDX Revenue FAQ

What is Insight Molecular Diagnostics’s yearly revenue?

Insight Molecular Diagnostics's yearly revenue for 2024 was $1.88M, representing an increase of 25.15% compared to 2023. The company's yearly revenue for 2023 was $1.5M, representing an increase of 56.89% compared to 2022. IMDX's yearly revenue for 2022 was $958K, representing a decrease of -87.60% compared to 2021.

What is Insight Molecular Diagnostics’s quarterly revenue?

Insight Molecular Diagnostics's quarterly revenue for Q2 2025 was $518K, a -75.77% decrease from the previous quarter (Q1 2025), and a 398.08% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $2.14M, a 43.88% increase from the previous quarter (Q4 2024), and a 1114.77% increase year-over-year (Q1 2024). IMDX's quarterly revenue for Q4 2024 was $1.49M, a 1192.17% increase from the previous quarter (Q3 2024), and a 373.25% increase year-over-year (Q4 2023).

What is Insight Molecular Diagnostics’s revenue growth rate?

Insight Molecular Diagnostics's revenue growth rate for the last 3 years (2022-2024) was 96.35%, and for the last 5 years (2020-2024) was 54.69%.

What are Insight Molecular Diagnostics’s revenue streams?

Insight Molecular Diagnostics's revenue streams in c 24 are Pharma Services

What is Insight Molecular Diagnostics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Insight Molecular Diagnostics was Pharma Services. This segment made a revenue of $1.86M, representing 100.00% of the company's total revenue.